Skip to content

Merit Medical Systems MMSI Endoscopy — Other Cost And Expense Operating

Similar metrics at other companies

Radian Group logo
RDNSpecialty Segment Operating — Other Cost And Expense Operating
$24.89M
Cheesecake Factory logo
CAKEAll Other Segments — Other Cost And Expense Operating
$28.68M+21.3%
Hecla Mining logo
HLAll Other Segments — Other Cost And Expense Operating
$13.37M
National Healthcare logo
NHCInpatient Services — Other Cost And Expense Operating
$81.08M-1.0%
GATX logo
GATXOther — Other operating expense
$300K-72.7%
GATX logo
GATXOther — Operating Costs and Expenses
$5.4M-11.5%

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Reported directly by Merit Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:OtherCostAndExpenseOperating.

The official record: Merit Medical Systems’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's endoscopy — other cost and expense operating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's endoscopy — other cost and expense operating?
Merit Medical Systems (MMSI) reported endoscopy — other cost and expense operating of $8.5K in Q4 2025.
What does endoscopy — other cost and expense operating mean?
This captures miscellaneous operating costs and expenses that are not classified under standard categories like COGS, SG&A, or R&D for the Endoscopy segment. It provides visibility into non-recurring or secondary operational expenditures that impact the segment's bottom line. Monitoring this helps identify unusual or ancillary costs affecting segment performance.